EpiCast Report: Postherpetic Neuralgia - Epidemiology Forecast to 2022

Publisher Name :
Date: 22-Oct-2013
No. of pages: 45

Postherpetic Neuralgia (PHN) is one of the most common complications of herpes zoster infection in elderly persons ages 60 years and older, worldwide. The main symptom of PHN is severe pain and allodynia (pain that results from a non-injurious stimulus to the skin). PHN is associated with a significant loss of activity levels and a reduced quality of life, particularly in the elderly. The strongest established risk factor for PHN is advancing age. Other possible risk factors for PHN include severity of acute herpes zoster pain, extent of rash, and duration of prodromal pain.

The number of incident cases of PHN in the 7MM will increase by 20.22% over the next decade, from 241,808 cases in 2012, to 290,694 cases in 2022. Ageand sex-specific incidence data for PHN and herpes zoster, as well as data for the proportion of herpes zoster patients developing PHN in the 7MM, were obtained or calculated from nationally-representative studies in each country to forecast the incident cases of PHN. To maintain a uniform methodology across the markets, GlobalData epidemiologists only used studies that defined PHN as pain persistent for three or more months.

Currently, there is no absolute preventative therapy for PHN. However, a vaccine is available to help prevent a herpes zoster infection; in turn, this vaccine helps reduce the incidence of PHN to an extent because PHN is the sequela of herpes zoster. The considerable increase in the aging population worldwide, coupled with the high risk for developing PHN in elderly herpes zoster patients are expected to impose a considerable burden on healthcare in the 7MM in future years.

Scope


  • The Postherpetic Neuralgia EpiCast Report provides an overview of the risk factors and global trends of postherpetic neuralgia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast (2012–2022) of the incident cases of postherpetic neuralgia segmented by age (in five-year increments beginning at age 50 and ending at age =85 years) and sex in the 7MM.

  • The postherpetic neuralgia epidemiology report is written and developed by Mastersand PhD-level epidemiologists.

  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.


Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global postherpetic neuralgia market.

  • Quantify patient populations in the global postherpetic neuralgia market to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for postherpetic neuralgia therapeutics in each of the markets covered.

EpiCast Report: Postherpetic Neuralgia - Epidemiology Forecast to 2022

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 Catalyst 7

3 Epidemiology 8
3.1 Disease Overview 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Elderly herpes zoster patients are almost 20 times more likely to develop PHN 9
3.2.2 Herpes zoster vaccine reduces the morbidity of herpes zoster and PHN 11
3.3 Global Trends 11
3.3.1 US 12
3.3.2 France 13
3.3.3 Germany 14
3.3.4 Italy 14
3.3.5 Spain 15
3.3.6 UK 16
3.3.7 Japan 17
3.4 Forecast Metodology 17
3.4.1 Sources Used 19
3.4.2 Forecast Assumptions and Methods 22
3.4.3 Sources Not Used 26
3.5 Epidemiological Forecast of Postherpetic Neuralgia (2012–2022) 27
3.5.1 Incident Cases of PHN 27
3.5.2 Age-Specific Incident Cases of PHN 28
3.5.3 Sex-Specific Incident Cases of PHN 30
3.5.4 Age-Standardized Incidence of PHN 32
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35

4 Appendix 37
4.1 Bibliography 37
4.2 About the Authors 40
4.2.1 Epidemiologists 40
4.2.2 Reviewers 40
4.2.3 Franka des Vignes, PhD, Global Director of Epidemiology and Health Policy 42
4.2.4 Bonnie Bain, PhD, Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 44

List of Tables

Table 1: 7MM, Sources of PHN Incidence Data 18
Table 2: 7MM, Incident Cases of PHN, Ages ?50 Years, Men and Women, N, 2012–2022 27
Table 3: 7MM, Incident Cases of PHN, by Age, Men and Women, N (Row %), 2012 29
Table 4: 7MM, Incident Cases of PHN, by Sex, Ages ?50 Years, N (Row %), 2012 31

List of Figures

Figure 1: 7MM, Incident Cases of PHN, Ages ?50 Years, Men and Women, N, 2012–2022 28
Figure 2: 7MM, Incident Cases of PHN, by Age, Men and Women, N, 2012 30
Figure 3: 7MM, Incident Cases of PHN, by Sex, Ages ?50 Years, N, 2012 31
Figure 4: 7MM, Age-Standardized Incidence of PHN (per 1,000 Population), Ages ?50 Years, Men and Women, 2012 33

  • Global Methadone Hydrochloride Market Research Report 2016
    Published: 05-Dec-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Methadone Hydrochloride Revenue, means the sales value of Methadone Hydrochloride This report studies Methadone Hydrochloride in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Eli Lilly - Sanofi Aventis - Roxane Laboratories - Ma......
  • Global Opioids Sales Market Report 2016
    Published: 29-Nov-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Opioids Revenue, means the sales value of Opioids This report studies sales (consumption) of Opioids in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi-aventis - Johnson & Johnson - Teva pharmaceuticals - Purdue Pharma - Pfizer......
  • Global Tramadol Market Research Report 2016
    Published: 25-Nov-2016        Price: US 2900 Onwards        Pages: 118
    Notes: Production, means the output of Tramadol Revenue, means the sales value of Tramadol This report studies Tramadol in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Grnenthal GmbH - Mundipharma - Hexal AG - Labopharm - Pliva Pharma - Nippon Shinyaku......
  • Musculoskeletal Pain-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Musculoskeletal Pain-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Musculoskeletal Pain. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, a......
  • Myalgia-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Myalgia-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Myalgia. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pat......
  • Non Malignant pain-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Non Malignant pain-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Non Malignant pain. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acqui......
  • Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Acute Pain Report is to understand the market and pipeline status of the drugs around the Acute Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipel......
  • Fibromyalgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Fibromyalgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Fibromyalgia Report is to understand the market and pipeline status of the drugs around the Fibromyalgia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing......
  • Acute Pain-API Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs